Sequential gemcitabine (G), oxaliplatin (O), and irinotecan (I) based weekly metronomic chemotherapy (MC) regimens for the treatment of metastatic pancreatic cancer (MPC): A community cancer clinic experience
Discover the sequential gemcitabine (G), oxaliplatin (O), and irinotecan (I) based weekly metronomic chemotherapy (MC) regimens for the treatment of metastatic pancreatic cancer (MPC) at Sibel Blau, dedicated to providing advanced and effective healthcare solutions in the Health category.
Read article